The manufacturers of aducanumab are already specified 6‐calendar year approval with the FDA to offer proof of medical benefit. Guidelines for its acceptable use are starting to be revealedEveryday living evaluation therapy is someone or team Tale‐telling intervention with a target integrating lifetime tales via diverse phases in everyday life.